eprintid: 63153
rev_number: 1
eprint_status: archive
userid: 1
dir: disk0/00/06/31/53
datestamp: 2026-05-26 15:53:47
lastmod: 2026-05-26 15:53:47
status_changed: 2026-05-26 15:53:47
type: article
metadata_visibility: show
sword_depositor: 1
creators_name: Bahodir, Akhmedov
title: CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF NEUROLEPTIC DRUGS IN DEPRESSIVE SYNDROME
ispublished: pub
subjects: neuroleptics, depressive syndrome, antipsychotics, pharmacology, dopamine antagonists, serotonin modulation.
keywords: neuroleptics, depressive syndrome, antipsychotics, pharmacology, dopamine antagonists, serotonin modulation.
note: Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/5405)
abstract: The clinical use of neuroleptic (antipsychotic) drugs in depressive syndromes represents a complex intersection between psychopharmacology and clinical psychiatry. Traditionally employed in the management of psychotic disorders, certain neuroleptic agents have demonstrated significant efficacy as adjuncts or augmenting agents in depressive disorders, particularly those resistant to conventional antidepressant therapy. Their pharmacological effects extend beyond dopamine receptor antagonism, encompassing modulation of serotonergic, noradrenergic, and glutamatergic neurotransmission. This article examines the pharmacodynamics, pharmacokinetics, clinical applications, and safety considerations of neuroleptic drugs in depressive syndromes, highlighting both their therapeutic potential and the challenges associated with their use.
date: 2025-10-29
date_type: published
publisher: Center for Tech and Media Research
official_url: https://mjstjournal.com/index.php/mjst/article/view/5405
id_number: oai:ojs.pkp.sfu.ca:article/5405
full_text_status: none
publication: Multidisciplinary Journal of Science and Technology
citation:   Bahodir, Akhmedov  (2025) CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF NEUROLEPTIC DRUGS IN DEPRESSIVE SYNDROME.  Multidisciplinary Journal of Science and Technology.